Hayfin Capital Management has named Marc Chowrimootoo as a managing director and portfolio manager. Previously, he worked at Goldman Sachs where he was a managing director in the European leveraged ...

Hayfin Capital announced a new strategic partnership with Samsung Life Insurance, marking the latest step in its post-management buyout strategy. As part of the deal, Samsung Life will acquire a ...

GREENWICH, Conn. and LONDON, Dec. 24, 2025 /PRNewswire/ -- Funds managed by Hayfin ("Hayfin"), and Strategic Value Partners, LLC and its affiliates ("SVP") (together, the "Lenders"), have reached an ...

PITTSBURGH, Jan. 6, 2025 /PRNewswire/ - MolecuLight Inc., a global medical device company pioneering point-of-care fluorescence imaging for measuring bacterial load in wounds, today announced it has ...

Transaction follows successful long-term partnership with BCI and delivers on Hayfin’s objectives for greater team ownership, alignment, and incentivization LONDON & NEW YORK & VICTORIA, British ...

CHICAGO--(BUSINESS WIRE)-- Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing ...

NEW YORK--(BUSINESS WIRE)--Kroll Bond Rating Agency (KBRA) assigns a preliminary rating to one class of notes issued by Hayfin Kingsland X, Ltd. (Hayfin Kingsland X). Hayfin Kingsland X is a ...

Transaction follows successful long-term partnership with BCI and delivers on Hayfin’s objectives for greater team ownership, alignment, and incentivization No changes expected to Hayfin’s strategy, ...

MolecuLight's innovative fluorescence imaging devices are transforming the way healthcare providers detect and treat infections. By providing real-time visualization of harmful bacteria in all wound ...

Transaction follows successful long-term partnership with BCI and delivers on Hayfin's objectives for greater team ownership, alignment, and incentivization No changes expected to Hayfin's strategy, ...